Business Description
DarioHealth Corp
NAICS : 923120
SIC : 7372
ISIN : US23725P1003
Description
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.51 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | -0.54 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -5.64 | |||||
| Beneish M-Score | -2.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -17.4 | |||||
| 3-Year EBITDA Growth Rate | 27.3 | |||||
| 3-Year EPS without NRI Growth Rate | 23.8 | |||||
| 3-Year FCF Growth Rate | 28.6 | |||||
| 3-Year Book Growth Rate | -14.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 22.62 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 32.56 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.93 | |||||
| 9-Day RSI | 51.46 | |||||
| 14-Day RSI | 47.78 | |||||
| 3-1 Month Momentum % | 12.66 | |||||
| 6-1 Month Momentum % | -31.54 | |||||
| 12-1 Month Momentum % | -45.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.57 | |||||
| Quick Ratio | 1.32 | |||||
| Cash Ratio | 0.82 | |||||
| Days Inventory | 133.43 | |||||
| Days Sales Outstanding | 86.3 | |||||
| Days Payable | 70.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -49.6 | |||||
| Shareholder Yield % | -6.85 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.9 | |||||
| Operating Margin % | -261.54 | |||||
| Net Margin % | -205.62 | |||||
| FCF Margin % | -170.79 | |||||
| ROE % | -71.65 | |||||
| ROA % | -41.44 | |||||
| ROIC % | -74.99 | |||||
| 3-Year ROIIC % | -49.49 | |||||
| ROC (Joel Greenblatt) % | -1608.26 | |||||
| ROCE % | -63.81 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.21 | |||||
| PB Ratio | 0.42 | |||||
| EV-to-EBIT | -0.62 | |||||
| EV-to-EBITDA | -0.69 | |||||
| EV-to-Forward-EBITDA | -2.35 | |||||
| EV-to-Revenue | 1.7 | |||||
| EV-to-Forward-Revenue | 0.64 | |||||
| EV-to-FCF | -0.99 | |||||
| Price-to-GF-Value | 0.37 | |||||
| Price-to-Median-PS-Value | 0.33 | |||||
| Earnings Yield (Greenblatt) % | -161.29 | |||||
| FCF Yield % | -148.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DRIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DarioHealth Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 23.052 | ||
| EPS (TTM) ($) | -0.94 | ||
| Beta | 1.13 | ||
| 3-Year Sharpe Ratio | -1.02 | ||
| 3-Year Sortino Ratio | -1.24 | ||
| Volatility % | 77.76 | ||
| 14-Day RSI | 47.78 | ||
| 14-Day ATR ($) | 0.071469 | ||
| 20-Day SMA ($) | 0.76269 | ||
| 12-1 Month Momentum % | -45.73 | ||
| 52-Week Range ($) | 0.661 - 2.6 | ||
| Shares Outstanding (Mil) | 34.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DarioHealth Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DarioHealth Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
DarioHealth Corp Frequently Asked Questions
What is DarioHealth Corp(DRIO)'s stock price today?
The current price of DRIO is $0.78. The 52 week high of DRIO is $2.60 and 52 week low is $0.66.
When is next earnings date of DarioHealth Corp(DRIO)?
The next earnings date of DarioHealth Corp(DRIO) is 2025-03-28 Est..
Does DarioHealth Corp(DRIO) pay dividends? If so, how much?
DarioHealth Corp(DRIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers